Trial intelligence / Profile preview

Pilot pharmacokinetic study of intravenous salbutamol in pediatric status asthmaticus

NL-OMON37955Active, not recruiting

Sponsor
Erasmus MC
Start
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of salbutamol in status asthmaticus, sponsored by Erasmus MC. Primary endpoint: Pharmacokinetic parameters of intravenous salbutamol. Started Sep 2011; status: active, not recruiting.

02

Drugs

salbutamol
03

Conditions

status asthmaticus

Beyond the preview

Go deeper on NL-OMON37955.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON37955.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call